Hermansky-Pudlak Syndrome and Chediak-Higashi Syndrome: Disorders of Vesicle Formation and Trafficking

Summary

The rare autosomal recessive metabolic disorders Hermanky-Pudlak syndrome (HPS) and Chediak-Higashi syndrome (CHS) share the clinical findings of oculocutaneous albinism and a platelet storage pool deficiency. In addition, HPS exhibits ceroid lipofuscinosis and CHS is characterized by infections and an accelerated phase. The two disorders result from defects in vesicles of lysosomal lineage. Of the two known HPS-causing genes, HPS1 has no recognizable function, while ADTB3A codes for a subunit of an adaptor complex responsible for new vesicle formation from the trans-Golgi network. Other HPS-causing genes are likely to exist. The only known CHS-causing gene, LYST, codes for a large protein of unknown function. In general, HPS appears to be a disorder of vesicle formation and CHS a defect in vesicle trafficking. These diseases and their variants mirror a group of mouse hypopigmentation mutants. The gene products involved will reveal how the melanosome, platelet dense body, and lysosome are formed and trafficked within cells.

Key words

Albinism - platelet dense bodies - giant lysosomes - LYST - intracellular trafficking

• References

• 1 Witkop CJ, Quevedo WC, Fitzpatrick TB, King RA. Albinism. In: The Metabolic Basis of Inherited Disease. Scriver CR, Beaudet AL, Sly WS, Valle DL. eds. 6th ed., vol. 2. New York: McGraw-Hill; 1989: 2905-47.
• 2 King RA, Hearing VJ, Creel DJ, Oetting WS. Albinism. In: The Metabolic and Molecular Bases of Inherited Disease. Scriver CR, Beaudet AL, Sly WS, Valle DL. eds. 7th ed., vol. 3. New York: McGraw-Hill; 1995: 4353-92.
• 3 Shotelersuk V, Gahl WA. Hermansky-Pudlak syndrome: Models for intracellular vesicle formation. Mol Genet Metab 1998; 65: 85-96.
• 4 Huizing M, Anikster Y, Gahl WA. Hermansky-Pudlak syndrome and related disorders of organelle formation. Traffic 2000; 1: 823-35.
• 5 Spritz RA. Hermansky-Pudlak syndrome and pale ear: Melanosome-making for the mellenium. Pigment Cell Res 2000; 13: 15-20.
• 6 Spritz RA. Chediak-Higashi syndrome. In: Primary Immunodeficiency Diseases: A Molecular and Genetic Approach. Ochs HD, Smith CIE, Puck JM. eds. New York: Oxford University Press; 1999: 389-96.
• 7 Hermansky F, Pudlak P. Albinism associated with hemorrhagic diathesis and unusual pigmented reticular cells in the bone marrow: Report of two cases with histochemical studies. Blood 1959; 14: 162-9.
• 8 Gahl WA, Brantly M, Kaiser-Kupfer MI, Iwata F, Hazelwood S, Shotelersuk V, Duffy LF, Kuehl EM, Troendle J, Bernardini I. Genetic defects and clinical characteristics of patients with a form of oculocutaneous albinism (Hermansky-Pudlak syndrome). N Engl J Med 1998; 338: 1258-64.
• 9 Toro J, Turner M, Gahl WA. Dermatologic manifestations of HermanskyPudlak syndrome in patients with and without a 16-base pair duplication in the HPS1 gene. Arch Dermatol 1999; 135: 774-80.
• 10 Simon JW, Adams RJ, Calhoun JH, Shapiro SS, Ingerman CM. Ophthalmic manifestations of the Hermansky-Pudlak syndrome (oculocutaneous albinism and hemorrhagic diathesis). Am J Ophthalmol 1982; 93: 71-7.
• 11 Summers CG, Knobloch WH, Witkop CJ, King RA. Hermansky-Pudlak Syndrome: Ophthalmic findings. Ophthalmol 1988; 95: 545-54.
• 12 Iwata F, Reed GF, Caruso RC, Kuehl EM, Gahl WA, Kaiser-Kupfer MI. Correlation of visual acuity and ocular pigmentation with the 16-bp duplication in the HPS-1 gene of Hermansky-Pudlak syndrome, a form of albinism. Ophthalmology 2000; 107: 783-9.
• 13 McNicol A, Israels SJ. Platelet dense granules: Structure, function and implications for haemostasis. Thromb Res 1999; 95: 1-18.
• 14 Witkop Jr CJ, Bowie EJ, Krumwiede MD, Swanson JL, Plumhoff EA, White JG. Synergistic effect of storage pool deficient platelets and low plasma von Willebrand factor on the severity of the hemorrhagic diathesis in Hermansky-Pudlak Syndrome. Am J Hematol 1993; 44: 256-9.
• 15 McKeown LP, Hansmann KE, Wilson O, Gahl WA, Gralnick HR, Rosen-feld KE, Rosenfeld SJ, Horne MK, Rick ME. Platelet von Willebrand factor in Hermansky-Pudlak Syndrome. Am J Hematol 1998; 59: 115-20.
• 16 Shanahan F, Randolph L, King R, Oseas R, Brogan M, Witkop C, Rotter J. Targan. Hermansky-Pudlak syndrome: An immunologic assessment of 15 cases. Am J Med 1988; 85: 823-8.
• 17 Garay SM, Gardella JE, Fazzini EP, Goldring RM. Hermansky-Pudlak Syndrome: Pulmonary manifestations of a ceroid storage disorder. Am J Med 1979; 66: 737-47.
• 18 Brantly M, Avila NA, Shotelersuk V, Lucero C, Huizing M, Gahl WA. Pulmonary function and high-resolution CT findings in patients with an inherited form of pulmonary fibrosis, Hermansky-Pudlak syndrome, due to mutations in HPS-1. Chest 2000; 117: 129-36.
• 19 Schinella RA, Greco MA, Cobert BL, Denmark LW, Cox RP. HermanskyPudlak syndrome with granulomatous colitis. Ann Intern Med 1980; 92: 20-3.
• 20 Mahadeo R, Markowitz J, Fisher S, Daum F. Hermansky-Pudlak syndrome with granulomatous colitis in children. J Pediatr 1991; 118: 904-6.
• 21 Dell’Angelica EC, Shotelersuk V, Aguilar RC, Gahl WA, Bonifacino JS. Altered trafficking of lysosomal proteins in Hermansky-Pudlak syndrome due to mutations in the β3A subunit of the AP-3 adaptor. Mol Cell 1999; 3: 11-21.
• 22 Shotelersuk V, Dell’Angelica EC, Hartnell L, Bonifacino JS, Gahl WA. A new variant of Hermansky-Pudlak syndrome due to mutations in a gene responsible for vesicle formation. Am J Med 2000; 108: 423-7.
• 23 Hazelwood S, Shotelersuk V, Wildenberg SC, Chen D, Iwata F, Kaiser-Kupfer MI, White JG, King RA, Gahl WA. Evidence for locus heterogeneity in Puerto Ricans with Hermansky-Pudlak syndrome. Am J Hum Genet 1997; 61: 1088-94.
• 24 Witkop CJ, Krumwiede M, Sedano H, White JG. Reliability of absent platelet dense bodies as a diagnostic criterion for Hermansky-Pudlak syndrome. Am J Hematol 1987; 26: 305-11.
• 25 Van Dorp DB, Wijermans PW, Meire F, Vrensen G. The HermanskyPudlak syndrome: Variable reaction to 1-desamino-8D-arginine vasopressin for correction of the bleeding time. Ophthal Paediatr Genet 1990; 11237-44.
• 26 Witkop CJ, Babcock MN, Rao GHR, Gaudier F, Summers CG, Shanahan F, Harmon KR, Townsend DW, Sedano HO, King RA, Cal SX, White JG. Albinism and Hermansky-Pudlak syndrome in Puerto Rico. Bol Asoc Med P Rico-Agosto 1990; 82: 333-9.
• 27 Oh J, Bailin T, Fukai K, Feng GH, Ho L, Mao J-i, Frenk E, Tamura N, Spritz RA. Positional cloning of a gene for Hermansky-Pudlak syndrome, a disorder of cytoplasmic organelles. Nat Genet 1996; 14: 300-6.
• 28 Oh J, Ho L, Ala-Mello S, Amato D, Armstrong L, Bellucci S, Carakushansky G, Ellis JP, Fong C-T, Green JS, Heon E, Legius E, Levin AV, Nieuwenhuis HK, Pinckers A, Tamura N, Whiteford ML, Yamasaki H, Spritz RA. Mutation analysis of patients with Hermansky-Pudlak syndrome: A frameshift hot spot in the HPS gene and apparent locus heterogeneity. Am J Hum Genet 1998; 62: 593-8.
• 29 Shotelersuk V, Hazelwood S, Larson D, Iwata F, Kaiser-Kupfer MI, Kuehl E, Bernardini I, Gahl WA. Three new mutations in a gene causing Hermansky-Pudlak syndrome: Clinical correlations. Mol Gen Metab 1998; 64: 99-107.
• 30 Oetting WS, King RA. Molecular basis of albinism: Mutations and polymorphisms of pigmentation genes associated with albinism. Hum Mutat 1999; 13: 99-115.
• 31 Swank RT, Novak EK, McGarry MP, Rusiniak ME, Feng L. Mouse models of Hermansky Pudlak syndrome: A review. Pigment Cell Res 1998; 11: 60-80.
• 32 Wildenberg SC, Oetting WS, Almodovar C, Krumwiede M, White JG, King RA. A gene causing Hermansky-Pudlak syndrome in a Puerto Rican population maps to chromosome 10q2. Am J Hum Genet 1995; 57: 755-65.
• 33 Bailin T, Oh J, Feng GH, Fukai K, Spritz RA. Organization and nucleotide sequence of the human Hermansky-Pudlak syndrome (HPS) gene. J Invest Dermatol 1997; 108: 923-7.
• 34 Wildenberg SC, Fryer JP, Gardner JM, Oetting WS, Brilliant MH, King RA. Identification of a novel transcript produced by the gene responsible for the Hermansky-Pudlak syndrome in Puerto Rico. J Invest Dermatol 1998; 110: 777-81.
• 35 Huizing M, Anikster Y, Gahl WA. Characterization of a partial pseudogene homologous to the Hermansky-Pudlak syndrome gene HPS-1; relevance for mutation detection. Hum Genet 2000; 106: 370-3.
• 36 Feng GH, Bailin T, Oh J, Spritz RA. Mouse pale ear (ep) is homologous to human Hermansky-Pudlak syndrome and contains a rare ‘AT-AC’ intron. Hum Mol Genet 1997; 6: 793-9.
• 37 Gardner JM, Wildenberg SC, Keiper NM, Novak EK, Rusiniak ME, Swank RT, Puri N, Finger JN, Hagiwara N, Lehman AL, Gales TL, Bayer ME, King RA, Brilliant MH. The mouse pale ear (ep) mutation is the homologue of human Hermansky-Pudlak syndrome. Proc Natl Acad Sci USA 1997; 94: 9238-43.
• 38 Dell’Angelica EC, Ooi CE, Bonifacino JS. 3A-adaptin, a subunit of the adaptor-like complex AP-3. J Biol Chem 1997; 272: 15078-84.
• 39 Schekman R, Orci L. Coat proteins and vesicle budding. Science (Wash DC) 1996; 271: 1526-33.
• 40 Feng L, Seymour AB, Jiang S, To A, Peden AA, Novak EK, Zhen L, Rusiniak ME, Eicher EM, Robinson MS, Gorin MB, Swank RT. The 3A subunit gene (Ap3b1) of the AP-3 adaptor complex is altered in the mouse hypopigmentation mutant pearl, a model for Hermansky-Pudlak syndrome and night blindness. Hum Mol Genet 1999; 8: 323-30.
• 41 Israels SJ, McMillan EM, Robertson C, Singhory S, McNicol A. The lysosomal granule membrane protein, LAMP-2, is also present in platelet dense granule membranes. Thromb Haemost 1996; 75: 623-9.
• 42 Oh J, Liu ZX, Feng GH, Raposo G, Spritz RA. The Hermansky-Pudlak syndrome (HPS) protein is part of a high molecular weight complex involved in biogenesis of early melanosomes. Hum Mol Genet 2000; 9: 375-85.
• 43 Barbosa MDFS, Nguyen QA, Tchemev VT, Ashley JA, Detter JC, Blaydes SM, Brandt SJ, Chotai D, Hodgman C, Solari RCE, Lovett M, Kingsmore SF. Identification of the homologous beige and ChediakHigashi syndrome genes. Nature 1996; 382: 262-5.
• 44 Jimbow K, Park JS, Kato F, Hirosaki K, Toyofuku K, Hua C, Yamashita T. Assembly, target-signaling and intracellular transport of tyrosinase gene family proteins in the initial stage of melanosome biogenesis. Pigment Cell Res 2000; 13: 222-9.
• 45 Johnson KF, Kornfeld S. A His-Leu-Leu sequence near the carboxyl terminus of the cytoplasmic domain of the cation-dependent mannose 6-phosphate receptor is necessary for the lysosomal enzyme sorting function. J Biol Chem 1992; 267: 17110-5.
• 46 Dell’Angelica E, Aguilar R, Wolins N, Hazelwood S, Gahl WA, Bonifacino JS. Molecular characterization of the protein encoded by the HermanskyPudlak Syndrome type 1 gene. J Biol Chem 2000; 275: 1300-6.
• 47 Boissy RE, Zhao Y. The role of the Hermansky-Pudlak gene product in intracellular trafficking of melanogenic proteins. J Invest Dermatol 1999; 112: 629 (Abstr 637).
• 48 Boissy RE, Zhao Y, Gahl WA. Altered protein localization in melanocytes from Hermansky-Pudlak syndrome: Support for the role of the HPS gene product in intracellular trafficking. Lab Invest 1998; 78: 1037-48.
• 49 Dell’Angelica EC, Klumperman J, Stoorvogel W, Bonifacino JS. Association of the AP-3 adaptor complex with clathrin. Science 1998; 280: 431-4.
• 50 Dell’Angelica EC, Ohno H, Ooi CE, Rabinovich E, Roche KW, Bonifacino JS. AP-3: an adaptor-like protein complex with ubiquitous expression. EMBO J 1997; 15: 917-28.
• 51 Simpson F, Bright NA, West MA, Newman LS, Darnell RB, Robinson MS. A novel adaptor-related protein complex. J Cell Biol 1996; 133: 749-60.
• 52 Simpson F, Peden AA, Christopoulou L, Robinson MS. Characterization of the adaptor-related protein complex, AP-3. J Cell Biol 1997; 137: 835-45.
• 53 Ohno H, Fournier MC, Poy G, Bonifacino JS. Structural determinants of interaction of tyrosine-based sorting signals with the adaptor medium chains. J Biol Chem 1996; 271: 29009-15.
• 54 Honig S, Sandoval IV, von Figura K. A di-leucine-based motif in the cytoplasmic tail of LIMP-II and tyrosine mediates selective binding of AP-3. EMBO J 1998; 17: 1304-14.
• 55 Kantheti P, Qiao X, Diaz ME, Peden AA, Meyer GE, Carskadon SL, Kapfhamer D, Sufalko D, Robinson MS, Noebels JL, Burmeister M. Mutation in AP-3in the mocha mouse links endosomal transport to storage deficiency in platelets, melanosomes, and synaptic vesicles. Neuron 1998; 21: 111-22.
• 56 Caplan S, Dell’Angelica EC, Gahl WA, Bonifacino JS. Trafficking of MHC class II molecules in human B-lymphoblasts deficient in the AP-3 adaptor complex. Immunol Lett 2000; 72: 113-7.
• 57 Huizing M, Boissy RE, Gahl WA. Hermansky-Pudlak syndrome (HPS): A model for intracellular vesicle formation and trafficking. J Inherit Metab Dis 2000; (Suppl. 01) 23: 284a (Abstr).
• 58 Huang L, Kuo Y-M, Gitschier J. The pallid gene encodes a novel, syntaxin 13-interacting protein involved in platelet storage pool deficiency. Nat Genet 1999; 23: 329-32.
• 59 Prekeris R, Klumperman J, Chen YA, Scheller RH. Syntaxin 13 mediates cycling of plasma membrane proteins via tubulovesicular recycling endosomes. J Cell Biol 1998; 143: 957-71.
• 60 Detter JC, Zhang Q, Mules EH, Novak EK, Mishra VS, Li W, McMurtrie EB, Tchernev VT, Wallace MR, Seabra MC, Swank RT, Kingsmore SF. Rab geranylgeranyl transferasemutation in the gunmetal mouse reduces Rab27 prenylation and platelet synthesis. Proc Natl Acad Sci USA 2000; 97: 4144-9.
• 61 Novick P, Zerial M. The diversity of Rab proteins in vesicle transport. Curr Opin Cell Biol 1997; 9: 496-504.
• 62 Wilson SM, Yip R, Swing DA, O’Sullivan TN, Zhang Y, Novak E, Swank RT, Russell LB, Copeland NG, Jenkins NA. A mutation in Rab27a causes the vesicle transport defects observed in ashen mice. Proc Natl Acad Sci USA 2000; 97: 7933-8.
• 63 Menasche G, Pastural E, Feldmann J, Certain S, Ersoy F, Dupuis S, Wulffraat N, Bianchi D, Fischer A, Le Deist F, de Saint Basile G. Mutations in RAB27A cause Griscelli syndrome associated with haemophagocytic syndrome. Nat Genet 2000; 25: 173-6.
• 64 Griscelli C, Durandy A, Guy-Grand D, Daguillard F, Herzog C, Prunicras M. A syndrome associating partial albinism and immunodeficiency. Am J Med 1978; 65: 691-702.
• 65 Lloyd V, Ramaswami M, Kramer H. Not just pretty eyes: Drosophila eyecolour mutations and lysosomal delivery. Trends Cell Biol 1998; 8: 257-9.
• 66 Ooi CE, Moreira JE, Dell’Angelica EC, Poy G, Wassarman DA, Bonifacino JS. Altered expression of a novel adaptin leads to defective pigment granule biogenesis in the Drosophila eye color mutant garnet. EMBO J 1997; 16: 4508-18.
• 67 Kretzschmar D, Poeck B, Roth H, Ernst R, Keller A, Porsch M, Strauss R, Pflugfelder GO. Defective pigment granule biogenesis and aberrant behavior caused by mutations in the Drosophila AP-3beta adaptin gene ruby. Genetics 2000; 155: 213-23.
• 68 Mullins C, Hartnell LM, Wassarman DA, Bonifacino JS. Defective expression of the β3 subunit of the AP-3 adaptor complex in the Drosophila pigmentation mutant carmine. Mol Gen Genet 1999; 262: 401-12.
• 69 Mullins C, Hartnell LM, Wassarman DA, Bonifacino JS. Mutations in subunits of the AP-3 adaptor complex result in defective pigment granule biogenesis in Drosophila melanogaster. Mol Biol Cell 1999; 10: 223a (Abstr).
• 70 Rehling P, Darsow T, Katzmann DJ, Emr SD. Formation of AP-3 transport intermediates requires VPS41 function. Nat Cell Biol 1999; 1: 346-53.
• 71 Shestopal SA, Makunin IV, Belyaeva ES, Ashburner M, Zhimulev IF. Molecular characterization of the deep orange (dor) gene of Drosophila melanogaster. Mol Gen Genet 1997; 253: 642-8.
• 72 Sevrioukov EA, He JP, Moghtabi N, Sunio A, Kramer H. A role for the deep orange and carnation eye color genes in lysosomal delivery in Drosophila. Mol Cell 1997; 4: 479-86.
• 73 Rieder SE, Emr SD. A novel RING finger protein complex essential for a late step in protein transport to the yeast vacuole. Mol Biol Cell 1997; 8: 2307-27.
• 74 Dorsow T, Rieder SE, Emr SD. A multispecificity syntaxin homologue, Vam3p, essential for autophagic and biosynthetic protein transport to the vacuole. J Cell Biol 1997; 138: 517-29.
• 75 Dorsow T, Burd CG, Emr SD. Acidic di-leucine motif essential for AP3-dependent sorting and restriction of the functional specificity of the Vam3p vacuolar t-SNARE. J Cell Biol 1998; 142: 913-22.
• 76 Lemmon SK, Traub LM. Sorting in the endosomal system in yeast and animal cells. Curr Opin Cell Biol 2000; 12: 457-66.
• 77 Introne W, Boissy RE, Gahl WA. Clinical, molecular, and cell biological aspects of Chediak-Higashi syndrome. Mol Genet Metab 1999; 68: 283-303.
• 78 McVey Ward D, Griffiths GM, Stinchcombe JC, Kaplan J. Analysis of the lysosomal storage disease Chediak-Higashi syndrome. Traffic 2000; 1: 816-22.
• 79 Beguez-Cesar AB. Neutropenia cronica maligna familiar con granulaciones atipicas de los leucocitos. Bol Soc Cubana Pediatr 1943; 15: 900-22.
• 80 Chediak M. Nouvelle anomalie leukocytaire de caractere constitutionnel et familiel. Rev Hematol 1952; 7: 362-7.
• 81 Higashi O. Congenital gigantism of peroxidase granules. Tohoku J Exp Med 1954; 59: 315-32.
• 82 Zhao H, Boissy YL, Abdel-Malek Z, King RA, Nordlund JJ, Boissy RE. On the analysis of the pathophysiology of Chediak-Higashi syndrome. Defects expressed by cultured melanocytes. Lab Invest 1994; 71: 25-34.
• 83 Valenzuela R, Morningstar WA. The ocular pigmentary disturbance of human Chediak-Higashi syndrome. A comparative light- and electron-microscopic study and review of the literature. Am J Clin Pathol 1981; 75: 591-6.
• 84 BenEzra D, Mengistu F, Cividalli G, Weizman Z, Merin S, Auerbach E. Chediak-Higashi Syndrome: Ocular findings. J Pediatr Ophthalmol Strabis 1980; 17: 68-74.
• 85 Apitz-Castro R, Cruz MR, Ledezma E, Merino F, Ramirez-Duque P, Dangelmeier C, Holmsen H. The storage pool deficiency in platelets from humans with the Chediak-Higashi syndrome: study of six patients. Br J Haematol 1985; 59: 471-83.
• 86 Buchanan GR, Handin RI. Platelet function in the Chediak-Higashi syndrome. Blood 1976; 47: 941-8.
• 87 Blume RS, Wolff SM. The Chediak-Higashi syndrome: studies in four patients and a review of the literature. Medicine 1972; 51: 247-80.
• 88 Kjeldsen L, Calafat J, Borregaard N. Giant granules of neutrophils in Chediak-Higashi syndrome are derived from azurophil granules but not from specific and gelatinase granules. J Leukocyte Biol 1998; 64: 72-7.
• 89 White JG, Krumwiede M. Normal-sized primary lysosomes are present in Chediak-Higashi syndrome neutrophils. Pediatr Res 1987; 22: 208-15.
• 90 Root RK, Rosenthal AS, Balestra DJ. Abnormal bactericidal, metabolic, and lysosomal functions of Chediak-Higashi syndrome leukocytes. J Clin Invest 1972; 51: 649-65.
• 91 Abo T, Roder JC, Abo W, Cooper MD, Balch CM. Natural killer (HNK-1+) cells in Chediak-Higashi patients are present in normal numbers but are abnormal in function and morphology. J Clin Invest 1982; 70: 193-7.
• 92 Wolff SM, Dale DC, Clark RA, Root RK, Kimball HR. The ChediakHigashi syndrome: studies of host defenses. Ann Intern Med 1972; 76: 293-306.
• 93 Haliotis T, Roder J, Klein M, Ortaldo J, Fauci AS, Herberman RB. Chediak-Higashi gene in humans. Impairment of natural-killer function. J Exp Med 1980; 151: 1039-48.
• 94 Klein M, Roder J, Haliotis T, Korec S, Jett JR, Herberman RB, Katz P, Fauci AS. Chediak-Higashi gene in humans. The selectivity of the defect in natural-killer and antibody-dependent cell-mediated cytotoxicity function. J Exp Med 1980; 151: 1049-58.
• 95 Padgett GA, Reiquam CW, Gorham JR, Henson JB, O’Mary CC. Comparative studies of the Chediak-Higashi syndrome. Am J Pathol 1967; 51: 553-71.
• 96 Rubin CM, Burke BA, McKenna RW, McClain KL, White JG, Nesbit ME, Filipovich AH. The accelerated phase of Chediak-Higashi syndrome. An expression of the virus-associated hemophagocytic syndrome? Cancer 1985; 56: 524-30.
• 97 Sheramata W, Kott HS, Cyr DP. The Chediak-Higashi-Steinbrinck syndrome. Presentation of three cases with features resembling spinocerebellar degeneration. Arch Neurol 1971; 25: 289-94.
• 98 Sung JH, Meyers JP, Stadlan EM, Cowen D, Wolf A. Neuropathological changes in Chediak-Higashi disease. J Neuropathol Exp Neurol 1968; 28: 86-118.
• 99 Diukman R, Tanigawara S, Cowan MJ, Golbus MS. Prenatal diagnosis of Chediak-Higashi syndrome. Prenat Diagn 1992; 12: 877-85.
• 100 Kazmierowski J, Elin R, Reynolds H, Durbin W, Wolff S. ChediakHigashi syndrome: reversal of increased susceptibility to infection by bone marrow transplantation. Blood 1976; 47: 555-9.
• 101 Haddad E, Le Deist F, Blanche S, Benkerrou M, Rohrlich P, Vilmer E, Griscelli C, Fischer A. Treatment of Chediak-Higashi syndrome by allogenic bone marrow transplantation: report of 10 cases. Blood 1995; 85: 3328-33.
• 102 Gallin JI, Elin RJ, Hubert RT, Fauci AS, Kaliner MA, Wolff SM. Efficacy of ascorbic acid in Chediak-Higashi syndrome (CHS): studies in humans and mice. Blood 1979; 53: 226-34.
• 103 Griscelli C, Virelizier JL. Bone marrow transplantation in a patient with Chediak-Higashi syndrome. Birth Defects Orig Artic Ser 1983; 19: 333-4.
• 104 Fukai K, Oh J, Karim MA, Moore KJ, Kandil HH, Ito H, Burger J, Spritz RA. Homozygosity mapping of the gene for Chediak-Higashi syndrome to chromosome 1q42-44 in a segment of conserved synteny that includes the mouse beige locus (bg). Am J Hum Genet 1996; 59: 620-4.
• 105 Barrat FJ, Auloge L, Pastural E, Lagelouse RD, Vilmer E, Cant AJ, Weissenbach J, Le Paslier D, Fischer A, de Saint Basile G. Genetic and physical mapping of the Chediak-Higashi syndrome on Chr 1q42-43. Am J Hum Genet 1996; 59: 625-32.
• 106 Perou CM, Moore KJ, Nagle DL, Misumi DJ, Woolf EA, McGrail SH, Holmgren L, Brody TH, Dussault BJ, Monroe CA, Duyk GM, Pryor RJ, Li L, Lustice MJ, Kaplan J. Identification of the murine beige gene by YAC complementation and positional cloning. Nat Genet 1996; 13: 303-8.
• 107 Barbosa MD, Barrat FJ, Tchemev VT, Nguyen QA, Mishra VS, Colman SD, Pastural E, Dufourcq-Lagelouse R, Fischer A, Holcombe RF, Wallace MR, Brandt SJ, de Saint Basile G, Kingsmore SF. Identification of mutations in two major mRNA isoforms of the Chediak-Higashi syndrome gene in human and mouse. Hum Mol Genet 1997; 6: 1091-8.
• 108 Karim MA, Nagle DL, Kandil HH, Burger J, Moore KJ, Spritz RA. Mutations in the Chediak-Higashi syndrome gene (CHS 1) indicate requirement for the complete 3801 amino acid CHS protein. Hum Mol Genet 1997; 6: 1087-9.
• 109 Nagle DL, Karim MA, Woolf EA, Holmgren L, Bork P, Misumi Dj, McGrail SH, Dussault BJ, Perou CM, Boissy RE, Duyk GM, Spritz RA, Moore KJ. Identification and mutation analysis of the complete gene for Chediak-Higashi syndrome. Nat Genet 1996; 14: 307-11.
• 110 Certain S, Barrat F, Pastural E, LeDeist F, Goyo-Rivas J, Jabado N, Benkerrou M, Seger R, Vilmer E, Beullier G, Schwartz K, Fischer A, de Saint Basile G. Protein truncation test of LYST reveals heterogeneous mutations in patients with Chediak-Higashi syndrome. Blood 2000; 95: 979-83.
• 111 Perou CM, Pryor RJ, Naas TP, Kaplan J. The bg allele mutation is due to a LINE1 element retrotranspositon. Genomics 1997; 42: 366-8.
• 112 Mori M, Nishikawa T, Higushi K, Nashimura A. Deletion in the beige gene of the beige rat owing to recombination between LINE1s. Mamm Genome 1999; 10: 692-5.
• 113 Pfeifer M, Berg S, Reynolds AB. A repeating amino acid motif shared by proteins with diverse cellular roles. Cell 1994; 76: 789-91.
• 114 Belmont LD, Mitchinson TJ. Identification of a protein that interacts with tubulin dimers and increases the catastrophe rate of microtubules. Cell 1996; 84: 623-31.
• 115 Ramsay M. Protein trafficking violations. Nat Genet 1996; 14: 242-5.
• 116 Faigle W, Raposo G, Amigorena S. Antigen presentation and lysosomal membrane traffick in the Chediak-Higashi syndrome. Protoplasma 2000; 210: 117-22.
• 117 Neer FJ, Schmidt CJ, Nambudripad R, Smith TF. The ancient regulatory protein family of WD-repeat proteins. Nature 1994; 371: 297-300.
• 118 Wang X, Herberg FW, Laue MM, Wullner C, Hu B, Petrasch-Parwez E, Kilimann MW. Neurobeachin: A protein kinase A-anchoring, beige/ Chediak-Higashi protein homolog implicated in neuronal membrane traffick. J Neurosci 2000; 20: 8551-65.
• 119 Adam-Klages S, Adam D, Wiegmann K, Struve S, Kolanus W, Schneider-Mergener J, Kronke M. FAN, a novel WD-repeat protein, couples the p55 TNF receptor to neutral sphingomyelinase. Cell 1996; 86: 937-47.
• 120 Feuchter AE, Freeman JD, Mager DL. Strategy for detecting cellular transcripts promoted by human endogenous long terminal repeats: identification of a novel gene (CDC4C) with homology to yeast CDC4. Genomics 1992; 13: 1237-46.
• 121 Rendu F, Breton-Gorius J, Lebret M, Klebanoff C, Buriot D, Griscelli C, Levy-Toledano S, Caen JP. Evidence that abnormal platelet functions in human Chediak-Higashi syndrome are the result of a lack of dense bodies. Am J Pathol 1983; 111: 307-14.
• 122 Stinchcombe JC, Page LJ, Griffiths GM. Secretory lysosome biogenesis in cytotoxic T lymphocytes from normal and Chediak-Higashi syndrome patients. Traffic 2000; 1: 435-44.
• 123 Faigle W, Raposo G, Tenza D, Pinet V, Vogt AB, Kropshofer H, Fischer A, de Saint-Basile G, Amigorena S. Deficient peptide loading and MHC class II endosomal sorting in a human genetic immunodeficiency disease: the Chediak-Higashi syndrome. J Cell Biol 1998; 141: 1121-34.
• 124 Buckhardt JK, Wiebel FA, Hester S, Argon Y. The giant organelles in Beige and Chediak-Higashi fibroblasts are derived from late endosomes and mature lysosomes. J Exp Med 1993; 178: 1845-56.
• 125 Jones KL, Stweart RM, Fowler M, Fukuda M, Holcombe RF. ChediakHigashi lymphoblastoid cell line: granule characteristics and expression of lysosome-associated membrane proteins. Clin Immunol Immunopathol 1992; 65: 219-26.
• 126 Frankel FR, Tucker RW, Bruce J, Stenberg R. Fibroblasts and macrophages of mice with the Chediak-Higashi syndrome have microtubules and actin cables. J Cell Biol 1978; 79: 401-8.
• 127 White JG. Platelet microtubules and giant granules in Chediak-Higashi syndrome. Am J Med Tech 1978; 44: 273-8.
• 128 Pryzwansky KB, Schliwa M, Boxer LA. Microtubule organization of un-stimulated and stimulated adherent human neutrophils in Chediak-Higashi syndrome. Blood 1985; 66: 1398-403.
• 129 Tanabe F, Cui S-H, Ito M. Abnormal down-regulation of PKC is responsible for giant granule formation in fibroblasts from CHS (beige) mice-a thiol proteinase inhibitor, E-64-d, prevents giant granule formation in beige fibroblasts. J Leukocyte Biol 2000; 67: 749-55.
• 130 Ito M, Tanabe F, Takami Y, Sato A, Shigeta S. Rapid down-regulation of protein kinase C in (Chediak-Higashi syndrome) beige mouse by phorbol ester. Biochem Biophys Res Commun 1988; 153: 648-56.
• 131 Ito M, Sato A, Tanabe F, Ishida E, Takami Y, Shigeta S. The thiol proteinase inhibitors improve the abnormal rapid down-regulation of protein kinase C and the impaired natural killer cell activity in (Chediak-Higashi syndrome) beige mouse. Biochem Biphys Res Commun 1998; 160: 433-40.
• 132 Coffer PJ. Phosphatidylinositol 3-kinase signalling: A tale of two kinase activities. In: Protein Kinase functions. Woodgett J. ed. Oxford University Press; 2000: 1-39.
• 133 Corvera S, D’Arrigo A, Stenmark H. Phosphoinositides in membrane traffic. Curr Opin Cell Biol 1999; 11: 460-5.
• 134 Wurmser AE, Gary JD, Emr SD. Phosphoinositide 3-kinase and their FYVE domain-containing effectors as regulators of vacuolar/lysosomal membrane trafficking pathways. J Biol Chem 1999; 274: 9129-32.
• 135 Brown WJ, DeWald DB, Emr SD, Plutner H, Balch WE. Role for the phophatidylinositol 3-kinase in the sorting and transport of newly synthesized lysosomal enzymes in mammalian cells. J Cell Biol 1995; 130: 781-96.
• 136 Davidson HW. Wortmannin causes mistargeting of procathepsin D. Evidence for the involvement of a phosphatidylinositol 3-kinase in vesicular transport to lysosomes. J Cell Biol 1995; 130: 797-805.
• 137 Klionsky DJ, Emr SD. A new class of lysosomal/vacuolar protein sorting signals. J Biol Chem 1990; 265: 5349-52.
• 138 Stack JH, Herman PK, Schu PV, Emr SD. A membrane-associated complex containing the VPS15 protein kinase and the VPS34 PI 3-kinase is essential for protein sorting to the yeast lysosome-like vacuole. EMBO J 1993; 12: 2195-204.
• 139 De Camilli P, Emr SD, McPherson PS, Novick P. Phospho-inositides as regulators in membrane traffic. Science 1996; 271: 1533-8.
• 140 Panaretou C, Domin J, Cockroft S, Waterfield MD. Characterization of p150, an adaptor protein for the human phosphatidylinositol(PtdIns) 3-kinase. J Biochem Chem 1997; 272: 2477-85.
• 141 Davies JP, Cotter PD, Ioannou YA. Cloning and mapping of human Rab7 and Rab9 cDNA sequences and identification of a Rab9 pseudogene. Genomics 1997; 41: 131-4.
• 142 Bucci C, Thomsen P, Nicoziani P, McCarthy J, van Deurs B. Rab7: A key to lysosome biogenesis. Mol Biol Cell 2000; 11: 467-80.
• 143 Stein MP, Feng Y, Wandinger-Ness A. Binding of Rab7 to human Vps34, a cytosolic phosphatidyl inositol-3-kinase is nucleotide dependent. Mol Biol Cell 2000; 11: Suppl 505a (Abstr).
• 144 Pastural E, Barrat FJ, Dufourcq-Lagelouse R, Certain S, Sanal O, Jabado N, Seger R, Griscelli C, Fischer A, de Saint Basile G. Griscelli disease maps to chromosome 15q21 and is associated with mutations in the myosin-Va gene. Nat Genet 1997; 16: 289-92.
• 145 Mercer JA, Seperack PK, Strobel MC, Copeland NG, Jenkins NA. Novel myosin heavy chain encoded by murine dilute coat colour locus. Nature 1991; 349: 709-13.